Literature DB >> 1348108

Antioxidant effect on renal scarring following infection of mannose-sensitive-piliated bacteria.

T Matsumoto1, Y Mitzunoe, N Ogata, M Tanaka, K Takahashi, J Kumazawa.   

Abstract

Renal scars have been considered to occur in later stages of chronic pyelonephritis. In our experimental pyelonephritis model, bacteria which possessed mannose-sensitive (MS) pili on the surface promoted renal scarring following inoculation to the renal parenchyma. Polyethylene glycol-modified superoxide dismutase (PEG-SOD) and 2-O-octadecylascorbic acid (CV3611) significantly suppressed scarring when administered orally or parenterally during the early stage of kidney infection with MS-piliated bacteria. These findings suggest that the superoxide and other active oxygens play an important role in renal scarring following infection and that PEG-SOD and CV3611 may be agents capable of preventing renal scarring following bacterial pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348108     DOI: 10.1159/000186741

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

1.  Caffeic acid phenethyl ester suppresses oxidative stress in Escherichia coli-induced pyelonephritis in rats.

Authors:  Sefa Celik; Sadik Gorur; Ozkan Aslantas; Suat Erdogan; Sabahattin Ocak; Sibel Hakverdi
Journal:  Mol Cell Biochem       Date:  2006-10-19       Impact factor: 3.396

2.  Effect of prednisolone on ascending renal infection due to biofilm disease and lower urinary tract obstruction in rats.

Authors:  M Haraoka; T Matsumoto; K Takahashi; S Kubo; M Tanaka; J Kumazawa
Journal:  Urol Res       Date:  1995

Review 3.  The effect of vitamin A on renal damage following acute pyelonephritis in children: a meta-analysis of randomized controlled trials.

Authors:  Guo-Qiang Zhang; Jin-Liang Chen; Yong Zhao
Journal:  Pediatr Nephrol       Date:  2015-05-19       Impact factor: 3.714

4.  Evaluation of the effects of ozone therapy on Escherichia coli-induced cytitis in rat.

Authors:  C Tasdemir; S Tasdemir; N Vardi; B Ates; Y Onal; S Erdogan; A Yucel; E Aglamis; Y Yakupogullari; R Altıntas; A Karaman
Journal:  Ir J Med Sci       Date:  2013-03-01       Impact factor: 1.568

5.  Vitamin E administration at the onset of fever prevents renal scarring in acute pyelonephritis.

Authors:  Zhina Sadeghi; Abdol-Mohammad Kajbafzadeh; Parvin Tajik; Maryam Monajemzadeh; Seyedmehdi Payabvash; Azadeh Elmi
Journal:  Pediatr Nephrol       Date:  2008-06-04       Impact factor: 3.714

6.  The effects of methylene blue on renal scarring due to pyelonephritis in rats.

Authors:  Burhan Aksu; Mustafa Inan; Mehmet Kanter; Fulya Oz Puyan; Hafize Uzun; Gulay Durmus-Altun; Saban Gurcan; Seval Aydin; Suleyman Ayvaz; Mehmet Pul
Journal:  Pediatr Nephrol       Date:  2007-03-28       Impact factor: 3.714

7.  The role of dexamethasone on decreasing urinary cytokines in children with acute pyelonephritis.

Authors:  Mostafa Sharifian; Navid Anvaripour; Abdollah Karimi; Alireza Fahimzad; Masoomeh Mohkam; Reza Dalirani; Fatemeh Gholikhani; Mohammad Ali Rafiee
Journal:  Pediatr Nephrol       Date:  2008-06-13       Impact factor: 3.714

8.  Evaluation of Effectiveness of Vitamins C and E on Prevention of Renal Scar due to Pyelonephritis in Rat.

Authors:  Fatemeh Emamghorashi; Seyed Mohamad Owji; Mohammad Motamedifar
Journal:  Adv Urol       Date:  2010-12-12

9.  Investigation of the Optimum Preparation of Peach Gum Polysaccharides and the In Vivo and In Vitro Therapeutic Effects on Acute Pyelonephritis.

Authors:  Feifei Zhang; Jie Bai; Yao Zheng; Shuai Liang; Lei Lei; Xin Deng; Weijun Li; Peng Liu; Guangzhong Yang; Yongshen Ren
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-12       Impact factor: 2.629

10.  Could pyelonephritic scarring be prevented by anti-inflammatory treatment? An experimental model of acute pyelonephritis.

Authors:  Elif Bahat Özdoğan; Tuğba Özdemir; Seçil Arslansoyu Çamlar; Mustafa Imamoğlu; Ümit Cobanoğlu; Bircan Sönmez; İlknur Tosun; Ismail Doğan
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.